Companies: 10,795·Total market cap: $144.5T
CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc.

CASINASDAQHealthcare
$0.15
+$0.00(+3.08%)
Market Cap$2331664
P/E Ratio
52W High$3.09
52W Low$0.135
Overview

CASI Pharmaceuticals, Inc. (CASI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CASI · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-3.16casi eps ttm · casi earnings per shareEarnings history
PE Ratio (TTM)casi pe ratio ttm · casi price to earningsPE Ratio deep dive
Revenue (TTM)$26.8Mcasi revenue ttm · casi annual revenueFull revenue history
Dividend YieldNo Dividenddoes casi pay dividends · casi dividend yieldDividend history
Shares Outstanding15.3Mcasi shares outstanding · casi floatShares outstanding history
Next EarningsTBAcasi earnings date · casi next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$28.5M▼ 15.77% YoY
202220232024
casi pharmaceuticals, inc. revenue · casi revenue 2024
FY 2024Net Income-$39.3M▼ 45.73% YoY
202220232024
casi pharmaceuticals, inc. net income · casi profit 2024
FY 2024EPS$-2.56▼ 26.73% YoY
202220232024
casi eps · casi pharmaceuticals, inc. earnings per share 2024
TTM:Revenue: $26.8MNet Income: -$49.4MEPS: $-3.16View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis casi a buy · casi analyst rating
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$0.15Current
$6.00Avg Target3886.71% upside
$6.00High
casi price target · casi 12 month forecast

Total: 6 · Buy rate: 100.0%

The CASI analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +3886.71% upside from the current price of $0.15.

Stock Performance

Full History
1D+0.00%
1W+0.33%
1M+3.08%
3M-84.27%
YTD-82.29%
1Y-92.20%
5Y-99.16%

About CASI Pharmaceuticals, Inc.

CEODavid A. Cory
IPO DateJun 12, 1996
Employees233
CountryUS

CASI Pharmaceuticals, Inc. is a biopharmaceutical firm focused on the development and market introduction of medical treatments and drugs across China, the United States, and globally. Its marketed pr…

what is casi pharmaceuticals, inc. · casi stock overview · casi pharmaceuticals, inc. company profile · who is casi pharmaceuticals, inc. ceo · casi NASDAQ · casi pharmaceuticals, inc. headquarters · casi pharmaceuticals, inc. business segments

About Stock Overview & Key Data

CASI Pharmaceuticals, Inc. (CASI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 12, 1996. As of the latest trading session, CASI stock price is $0.15, with a market capitalization of $2.3M. The stock has returned -92.20% over the past 12 months and -82.29% year-to-date.

According to 6 Wall Street analysts, the consensus rating for CASI Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2024, CASI Pharmaceuticals, Inc. reported revenue of $28.5M and net income of -$39.3M. For detailed data — including CASI Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CASI Pharmaceuticals, Inc. (CASI) stock price is $0.15. The stock is traded on NASDAQ under the ticker symbol CASI. The 52-week range is $0.14 – $3.09.

CASI stock priceCASI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice